174 related articles for article (PubMed ID: 35932760)
1. Endogenous ligand recognition and structural transition of a human PTH receptor.
Kobayashi K; Kawakami K; Kusakizako T; Miyauchi H; Tomita A; Kobayashi K; Shihoya W; Yamashita K; Nishizawa T; Kato HE; Inoue A; Nureki O
Mol Cell; 2022 Sep; 82(18):3468-3483.e5. PubMed ID: 35932760
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides.
Pioszak AA; Parker NR; Gardella TJ; Xu HE
J Biol Chem; 2009 Oct; 284(41):28382-28391. PubMed ID: 19674967
[TBL] [Abstract][Full Text] [Related]
3. Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor.
Dean T; Vilardaga JP; Potts JT; Gardella TJ
Mol Endocrinol; 2008 Jan; 22(1):156-66. PubMed ID: 17872377
[TBL] [Abstract][Full Text] [Related]
4. Molecular recognition of two endogenous hormones by the human parathyroid hormone receptor-1.
Zhao LH; Yuan QN; Dai AT; He XH; Chen CW; Zhang C; Xu YW; Zhou Y; Wang MW; Yang DH; Xu HE
Acta Pharmacol Sin; 2023 Jun; 44(6):1227-1237. PubMed ID: 36482086
[TBL] [Abstract][Full Text] [Related]
5. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.
Yang Y; Wang B
Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
Cupp ME; Nayak SK; Adem AS; Thomsen WJ
J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors.
Hoare SR; Usdin TB
Curr Pharm Des; 2001 May; 7(8):689-713. PubMed ID: 11375776
[TBL] [Abstract][Full Text] [Related]
8. Mutation of phenylalanine-34 of parathyroid hormone disrupts NHERF1 regulation of PTH type I receptor signaling.
Wheeler D; Sneddon WB
Endocrine; 2006 Dec; 30(3):343-52. PubMed ID: 17526947
[TBL] [Abstract][Full Text] [Related]
9. Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling.
Hattersley G; Dean T; Corbin BA; Bahar H; Gardella TJ
Endocrinology; 2016 Jan; 157(1):141-9. PubMed ID: 26562265
[TBL] [Abstract][Full Text] [Related]
10. Dimeric arrangement of the parathyroid hormone receptor and a structural mechanism for ligand-induced dissociation.
Pioszak AA; Harikumar KG; Parker NR; Miller LJ; Xu HE
J Biol Chem; 2010 Apr; 285(16):12435-44. PubMed ID: 20172855
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid Hormone Senses Extracellular Calcium To Modulate Endocrine Signaling upon Binding to the Family B GPCR Parathyroid Hormone 1 Receptor.
Culhane KJ; Belina ME; Sims JN; Cai Y; Liu Y; Wang PSP; Yan ECY
ACS Chem Biol; 2018 Aug; 13(8):2347-2358. PubMed ID: 29952553
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone and parathyroid hormone-related peptide, and their receptors.
Gensure RC; Gardella TJ; Jüppner H
Biochem Biophys Res Commun; 2005 Mar; 328(3):666-78. PubMed ID: 15694400
[TBL] [Abstract][Full Text] [Related]
13. Abaloparatide, the second generation osteoanabolic drug: Molecular mechanisms underlying its advantages over the first-in-class teriparatide.
Bhattacharyya S; Pal S; Chattopadhyay N
Biochem Pharmacol; 2019 Aug; 166():185-191. PubMed ID: 31136739
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations.
Dean T; Linglart A; Mahon MJ; Bastepe M; Jüppner H; Potts JT; Gardella TJ
Mol Endocrinol; 2006 Apr; 20(4):931-43. PubMed ID: 16339275
[TBL] [Abstract][Full Text] [Related]
15. The parathyroid hormone (PTH)/PTH-related peptide receptor mediates actions of both ligands in murine bone.
Lanske B; Divieti P; Kovacs CS; Pirro A; Landis WJ; Krane SM; Bringhurst FR; Kronenberg HM
Endocrinology; 1998 Dec; 139(12):5194-204. PubMed ID: 9832460
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of ligand binding to the parathyroid hormone/parathyroid hormone-related peptide receptor in MCF7 breast cancer cells and SaOS-2 osteosarcoma cells.
Alokail MS; Peddie MJ
Cell Biochem Funct; 2007; 25(2):139-47. PubMed ID: 16170852
[TBL] [Abstract][Full Text] [Related]
17. Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragments.
Sneddon WB; Magyar CE; Willick GE; Syme CA; Galbiati F; Bisello A; Friedman PA
Endocrinology; 2004 Jun; 145(6):2815-23. PubMed ID: 15016722
[TBL] [Abstract][Full Text] [Related]
18. Ca
White AD; Fang F; Jean-Alphonse FG; Clark LJ; An HJ; Liu H; Zhao Y; Reynolds SL; Lee S; Xiao K; Sutkeviciute I; Vilardaga JP
Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3294-3299. PubMed ID: 30718391
[TBL] [Abstract][Full Text] [Related]
19. Structurally diverse N-terminal peptides of parathyroid hormone (PTH) and PTH-related peptide (PTHRP) inhibit the Na+/H+ exchanger NHE3 isoform by binding to the PTH/PTHRP receptor type I and activating distinct signaling pathways.
Azarani A; Goltzman D; Orlowski J
J Biol Chem; 1996 Jun; 271(25):14931-6. PubMed ID: 8663042
[TBL] [Abstract][Full Text] [Related]
20. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
